openPR Logo
Press release

Asia-Pacific Continuous Bioprocessing Market, Estimated to Reach $181.1 Million by 2030

03-14-2024 11:09 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Meticulous Research®

Asia-Pacific Continuous Bioprocessing Market, Estimated

Redding California, March 14, 2024 - Meticulous Research®, a leading provider of strategic market insights, has announced the publication of an exclusive report titled "Asia-Pacific Continuous Bioprocessing Market: Product, Application, and End User Analysis and Forecast, 2023-2030." According to this comprehensive analysis, the Asia-Pacific continuous bioprocessing market is anticipated to grow at an impressive CAGR of 28.9% from 2023, reaching a valuation of $181.1 million by 2030.

Download free sample report here: https://www.meticulousresearch.com/download-sample-report/cp_id=5682

Continuous bioprocessing, increasingly embraced in biopharmaceutical manufacturing, offers agility, flexibility, efficiency, and robustness. This approach optimizes processes by reducing steps, utilizing smaller facilities and equipment, and enhancing product quality for real-time release.

While small-scale perfusion currently dominates continuous bioprocessing, its advantages, including cost-effectiveness and product quality enhancement, are poised to propel its adoption in large-scale biopharmaceutical production in the near future. Key components of continuous bioprocessing include instruments and consumables such as filtration, chromatography, centrifugation, bioreactors, and more.

Browse in depth: https://www.meticulousresearch.com/product/asia-pacific-continuous-bioprocessing-market-5682

The growth of this market is fueled by the push in biotech R&D towards establishing a biotherapeutic landscape, improvements in the regulatory framework for biosimilars, and increased biopharmaceutical investments, expansions in CDMOs, and advancements in bioprocessing technologies. Moreover, the shift towards bioprocessing 4.0 and the rising adoption of personalized medicines present substantial growth opportunities.

However, challenges associated with continuous bioprocessing may hinder market growth.

Supportive Government and Corporate Initiatives Drive Market Expansion in Asia-Pacific
Several governments across the Asia-Pacific region are incentivizing the adoption of continuous bioprocessing due to its advantages, including consistent product quality, enhanced productivity, reduced equipment size, streamlined processes, and cost efficiency. Examples include:
Biocon's $75 million investment in Biocon Biologics to bolster biosimilar development in India (January 2021).

Download request sample report here: https://www.meticulousresearch.com/request-sample-report/cp_id=5682

Extension of partnership between Alvotech and Fuji Pharma to commercialize four biosimilars in Japan (December 2020).
China's significant investments in biopharma industrial hubs, contributing over $300 billion to the biological industry by 2020.

Launch of a pilot Marketing Authorization Holdership (MAH) program in China in 2017, accelerating biosimilar R&D and manufacturing.

The report also provides an extensive evaluation of growth strategies employed by major market players over the past four years. The Asia-Pacific continuous bioprocessing market has witnessed numerous organic and inorganic strategic developments during this period.

Quick buy: https://www.meticulousresearch.com/Checkout/26586719

Key Players:
Leading players profiled in this market study include 3M Company, Cytiva, Thermo Fisher Scientific Inc., Merck KGaA, Sartorius AG, Repligen Corporation, Eppendorf AG, Applikon Biotechnology, Pall Corporation, Solida Biotech GmBH, Electrolab Biotech Limited, Biowest, and Bionet.

Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asia-Pacific Continuous Bioprocessing Market, Estimated to Reach $181.1 Million by 2030 here

News-ID: 3429488 • Views:

More Releases from Meticulous Research®

Lysine Market Size, Growth Outlook, and Emerging Trends (2025-2032)
Lysine Market Size, Growth Outlook, and Emerging Trends (2025-2032)
The global lysine market is witnessing robust growth, reflecting a fundamental shift in global dietary patterns and livestock production systems. Valued at USD 7.77 billion in 2024, the market is projected to reach USD 15.09 billion by 2032 from USD 8.41 billion in 2025, expanding at a CAGR of 8.7% during the forecast period from 2025 to 2032. This significant growth is primarily driven by increasing demand for protein-rich diets,
Chitosan Market: Growth Trends, Sustainability Focus, and Future Outlook to 2032
Chitosan Market: Growth Trends, Sustainability Focus, and Future Outlook to 2032
Chitosan Market Overview The global chitosan market is witnessing remarkable growth as industries increasingly turn to sustainable and biodegradable materials. Valued at USD 2.55 billion in 2024, the market is projected to reach USD 6.51 billion by 2032, growing from USD 2.87 billion in 2025 at a CAGR of 12.4% during the forecast period from 2025 to 2032. This growth is driven by the expanding applications of chitosan in the pharmaceutical,
Minimal Residual Disease Testing Market: Trends, Innovations, and Forecast to 2031
Minimal Residual Disease Testing Market: Trends, Innovations, and Forecast to 20 …
Minimal Residual Disease Testing Market Overview The global minimal residual disease (MRD) testing market is witnessing rapid growth as precision oncology and early cancer detection gain momentum across healthcare systems worldwide. The market is expected to reach USD 4.45 billion by 2031, growing at a CAGR of 14.6% from 2024 to 2031. This growth is driven by the increasing incidence of cancer, rising awareness about early detection, and the growing application
Moringa Extract Market Size, Growth Trends, and Forecast to 2031
Moringa Extract Market Size, Growth Trends, and Forecast to 2031
The global moringa extract market has gained remarkable traction in recent years, driven by the growing consumer focus on natural wellness and sustainable nutrition. Valued at USD 5.06 billion in 2023, the market is projected to reach USD 10.65 billion by 2031, growing from an estimated USD 5.53 billion in 2024 at a CAGR of 9.8% during the forecast period from 2024 to 2031. This strong growth trajectory is fueled

All 5 Releases


More Releases for Continuous

Global Continuous Testing Market Size by Application, Type, and Geography: Forec …
USA, New Jersey- According to Market Research Intellect, the global Continuous Testing market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period. The market for continuous testing is expanding rapidly as businesses look for software that can be delivered more quickly and reliably. Continuous testing has
Continuous Blood Glucose Monitoring Market Report 2024 - Continuous Blood Glucos …
"The Business Research Company recently released a comprehensive report on the Global Continuous Blood Glucose Monitoring Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free
Continuous Integration Tools Market Report 2024 - Continuous Integration Tools M …
"The Business Research Company recently released a comprehensive report on the Global Continuous Integration Tools Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The continuous integration tools
Continuous-Blood Glucose Monitoring Market - Continuous Monitoring, Embracing St …
Newark, New Castle, USA - new report, titled Continuous-Blood Glucose Monitoring Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Continuous-Blood Glucose Monitoring market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Continuous-Blood Glucose Monitoring market. The report offers an overview of
Continuous Renal Replacement Therapy (CRRT) Market Report 2018: Segmentation by …
Global Continuous Renal Replacement Therapy (CRRT) market research report provides company profile for Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Bellco, NxStage Medical, Inc., Nipro Corporation, NIKKISO CO., LTD., Toray Medical Company Limited, INFOMED SA and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018
Continuous ‘everything‘ in practice
Moehrendorf, 2 October 2018 – Speed is becoming the key success factor in software development. Continuous integration, delivery and deployment need, however, the corresponding knowledge and the right tools. The Software-QS-Tag 2018 presents both. Also this year the leading conference about software quality assurance and testing in the German-speaking area is accompanied by a technical exhibition. On the whole, 18 associations, service providers, tool suppliers and publishing houses present their solutions